VTVT
VTVT
NASDAQ · Biotechnology

Vtv Therapeutics Inc- Cl A

$40.53
+0.87 (+2.19%)
As of Apr 1, 10:08 PM ET ·
Financial Highlights (FY 2026)
Revenue
687.2K
Net Income
-12,476,417
Gross Margin
Profit Margin
-1,815.3%
Rev Growth
-36.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 37.0% 37.0%
Operating Margin -2,377.6% -2,139.8% 23.4% 24.6%
Profit Margin -1,815.3% -1,724.6% 23.6% 25.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 687.2K 1.09M 10.43M 9.09M
Gross Profit 3.86M 3.36M
Operating Income -16,338,159 -23,229,609 2.44M 2.24M
Net Income -12,476,417 -17,738,981 2.46M 2.32M
Gross Margin 37.0% 37.0%
Operating Margin -2,377.6% -2,139.8% 23.4% 24.6%
Profit Margin -1,815.3% -1,724.6% 23.6% 25.5%
Rev Growth -36.7% -36.7% +12.7% +12.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 73.02M 57.41M
Total Equity 50.37M 60.82M
D/E Ratio 1.45 0.94
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -16,273,435 -24,423,006 3.49M 2.84M
Free Cash Flow 3.25M 2.35M